Livio Trusolino

Cytowane przez

	Wszystkie	Od 2018
Cytowania	19183	10381
h-indeks	66	47
i10-indeks	111	92

2300

1150

575

1725

1998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202350 61 80 78 148 185 199 230 235 250 259 280 397 442 562 668 873 994 1180 1423 1365 1663 1894 2190 2222 1030

Dostęp publiczny

Wyświetl wszystko

72 artykuły

2 artykuły

dostępne

niedostępne

Objęte finansowaniem

Współautorzy

Andrea BertottiUniversity of Torino - School of MedicineZweryfikowany adres z ircc.it
Alberto BardelliUniversity of Torino - Candiolo Cancer Institute IRCCSZweryfikowany adres z ircc.it
francesco sassiIRCC-University of Torino School of Medicine, Laboratory of Molecular Pharmacology ItalyZweryfikowany adres z ircc.it
Enzo MedicoProfessor of Histology, University of Torino and Head of the Laboratory of Oncogenomics, CandioloZweryfikowany adres z ircc.it
Salvatore SienaUniversità degli Studi di Milano, Dipartimento di Oncologia, Ospedale Niguarda, Milano, ItalyZweryfikowany adres z unimi.it
Claudio IsellaIRCCZweryfikowany adres z ircc.it
Andrea Sartore-BianchiClinical Molecular Oncology, Niguarda Cancer Center, Milano - ItalyZweryfikowany adres z ospedaleniguarda.it
Luca LazzariIFOM - FIRC Institute of Molecular OncologyZweryfikowany adres z ifom.eu
Fortunato CiardielloProfessore di oncologia medica, seconda università di napoliZweryfikowany adres z unina2.it
Jos JonkersSenior Group Leader, Division of Molecular Pathology, Netherlands Cancer Institute, Oncode InstituteZweryfikowany adres z nki.nl
Simona CorsoUniversity of TorinoZweryfikowany adres z ircc.it
Charlotte RolnyAssociate professor of tumor biology, Karolinska Institute, SwedenZweryfikowany adres z ki.se
Alessandro AMOREOspedale Regina Margherita Torino, Università degli studi TorinoZweryfikowany adres z unito.it
Massimiliano MazzoneGroup Leader, Vesalius Research CenterZweryfikowany adres z vib-kuleuven.be
Lorenzo CapussottiChief of the Surgical Deparment- Ospedale Mauriziano "Umberto I" TorinoZweryfikowany adres z mauriziano.it
Andrea CasazzaDirector Biology @ Montis Bioscience, BelgiumZweryfikowany adres z montisbio.com
Guido SeriniProfessor, University of Torino School of Medicine | Candiolo Cancer Institute IRCCSZweryfikowany adres z ircc.it
Dario RiberoDirigente Medico I livello, Divisione di Chirurgia Generale ed Oncologica, Ospedale Mauriziano Umberto IZweryfikowany adres z mauriziano.it
Lodewyk WesselsProfessor of Computational Cancer BiologyZweryfikowany adres z nki.nl
Giuseppe Bassoprofessor of pediatrics university paduaZweryfikowany adres z unipd.it

Obserwuj

Livio Trusolino

Professor, University of Torino School of Medicine, Italy

Zweryfikowany adres z ircc.it - Strona główna

Targeted anti-cancer therapies animal models oncogenic signal transduction pathways


Tytuł Sortuj wg cytatów Sortuj wg roku Sortuj wg tytułu	Cytowane przez Cytowane przez	Rok
Patient-derived xenograft models: an emerging platform for translational cancer research M Hidalgo, F Amant, AV Biankin, E Budinská, AT Byrne, C Caldas, ... Cancer discovery 4 (9), 998-1013, 2014	1489	2014
MET signalling: principles and functions in development, organ regeneration and cancer L Trusolino, A Bertotti, PM Comoglio Nature reviews Molecular cell biology 11 (12), 834-848, 2010	1228	2010
Drug development of MET inhibitors: targeting oncogene addiction and expedience PM Comoglio, S Giordano, L Trusolino Nature reviews Drug discovery 7 (6), 504-516, 2008	942	2008
A Molecularly Annotated Platform of Patient-Derived Xenografts (“Xenopatients”) Identifies HER2 as an Effective Therapeutic Target in Cetuximab-Resistant Colorectal CancerHER2 … A Bertotti, G Migliardi, F Galimi, F Sassi, D Torti, C Isella, D Corà, ... Cancer discovery 1 (6), 508-523, 2011	934	2011
Scatter-factor and semaphorin receptors: cell signalling for invasive growth L Trusolino, PM Comoglio Nature reviews cancer 2 (4), 289-300, 2002	876	2002
Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of … A Sartore-Bianchi, L Trusolino, C Martino, K Bencardino, S Lonardi, ... The Lancet Oncology 17 (6), 738-746, 2016	825	2016
Prioritization of cancer therapeutic targets using CRISPR–Cas9 screens FM Behan, F Iorio, G Picco, E Gonçalves, CM Beaver, G Migliardi, ... Nature 568 (7753), 511-516, 2019	823	2019
Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer A Bardelli, S Corso, A Bertotti, S Hobor, E Valtorta, G Siravegna, ... Cancer discovery 3 (6), 658-673, 2013	652	2013
Stromal contribution to the colorectal cancer transcriptome C Isella, A Terrasi, SE Bellomo, C Petti, G Galatola, A Muratore, A Mellano, ... Nature genetics 47 (4), 312-319, 2015	588	2015
Interrogating open issues in cancer precision medicine with patient-derived xenografts AT Byrne, DG Alférez, F Amant, D Annibali, J Arribas, AV Biankin, A Bruna, ... Nature Reviews Cancer 17 (4), 254-268, 2017	578	2017
A signaling adapter function for α6β4 integrin in the control of HGF-dependent invasive growth L Trusolino, A Bertotti, PM Comoglio Cell 107 (5), 643-654, 2001	561	2001
The genomic landscape of response to EGFR blockade in colorectal cancer A Bertotti, E Papp, S Jones, V Adleff, V Anagnostou, B Lupo, M Sausen, ... Nature 526 (7572), 263-267, 2015	422	2015
The Met tyrosine kinase receptor in development and cancer A Gentile, L Trusolino, PM Comoglio Cancer and metastasis reviews 27, 85-94, 2008	361	2008
Intrinsic resistance to MEK inhibition in KRAS mutant lung and colon cancer through transcriptional induction of ERBB3 C Sun, S Hobor, A Bertotti, D Zecchin, S Huang, F Galimi, F Cottino, ... Cell reports 7 (1), 86-93, 2014	325	2014
Hypertension-associated point mutations in the adducin alpha and beta subunits affect actin cytoskeleton and ion transport. G Tripodi, F Valtorta, L Torielli, E Chieregatti, S Salardi, L Trusolino, ... The Journal of clinical investigation 97 (12), 2815-2822, 1996	319	1996
Interactions between growth factor receptors and adhesion molecules: breaking the rules PM Comoglio, C Boccaccio, L Trusolino Current opinion in cell biology 15 (5), 565-571, 2003	308	2003
Oncogene addiction as a foundational rationale for targeted anti‐cancer therapy: promises and perils D Torti, L Trusolino EMBO molecular medicine 3 (11), 623-636, 2011	284	2011
Series Introduction: Invasive growth: from development to metastasis PM Comoglio, L Trusolino The Journal of clinical investigation 109 (7), 857-862, 2002	275	2002
HER2 activating mutations are targets for colorectal cancer treatment SM Kavuri, N Jain, F Galimi, F Cottino, SM Leto, G Migliardi, ... Cancer discovery 5 (8), 832-841, 2015	264	2015
Adaptive mutability of colorectal cancers in response to targeted therapies M Russo, G Crisafulli, A Sogari, NM Reilly, S Arena, S Lamba, A Bartolini, ... Science 366 (6472), 1473-1480, 2019	261	2019

Nie można teraz wykonać tej operacji. Spróbuj ponownie później.

Prace 1–20

Cytowania rocznie

Powielone cytowania

Scalone cytowania

Dodaj współautorówWspółautorzy

Obserwuj

Cytowane przez

Współautorzy